Institution

Instituto do Cérebro

Porto Alegre, BrazilWebsite

Also known as: Brain Institute of Rio Grande do Sul · Brain Institute of Rio Grande do Sul – PUCRS · InsCer - Instituto do Cérebro · Instituto do Cérebro da PUCRS · Instituto do Cérebro da Pontifícia Universidade Católica do Rio Grande do Sul · Instituto do Cérebro do RS

2running trials
1,042publications (OpenAlex)

Running trials

Recruiting
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT06290141· Phase 3· Sanofi· Source
Active, not recruiting
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
NCT06141473· Phase 3· Sanofi· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting

Registry name variants (2)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

InsCer - Instituto do Cérebro da PUCRS- Site Number : 0760002
Porto Alegre, Rio Grande do Sul 90610-000
1 trial
- NCT06290141A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
InsCer - Instituto do Cérebro da PUCRS- Site Number : 0761009
Porto Alegre, Rio Grande do Sul 90610-000
1 trial
- NCT06141473Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Institution data: ROR 007j2dm88 (CC0-1.0)Updated 14 Nov 2026

Report an error